CN100581589C - 放射标记的氨基酸类似物,其制备物及用途 - Google Patents
放射标记的氨基酸类似物,其制备物及用途 Download PDFInfo
- Publication number
- CN100581589C CN100581589C CN03818609A CN03818609A CN100581589C CN 100581589 C CN100581589 C CN 100581589C CN 03818609 A CN03818609 A CN 03818609A CN 03818609 A CN03818609 A CN 03818609A CN 100581589 C CN100581589 C CN 100581589C
- Authority
- CN
- China
- Prior art keywords
- labelling
- jibingsuan
- pyridine radicals
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (20)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02078228.0 | 2002-08-02 | ||
EP02078228 | 2002-08-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1674943A CN1674943A (zh) | 2005-09-28 |
CN100581589C true CN100581589C (zh) | 2010-01-20 |
Family
ID=33547582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN03818609A Expired - Fee Related CN100581589C (zh) | 2002-08-02 | 2003-08-01 | 放射标记的氨基酸类似物,其制备物及用途 |
Country Status (10)
Country | Link |
---|---|
US (2) | US7189383B2 (zh) |
EP (1) | EP1539250A1 (zh) |
JP (1) | JP2006516547A (zh) |
KR (1) | KR20050033067A (zh) |
CN (1) | CN100581589C (zh) |
AU (1) | AU2003304200B2 (zh) |
CA (1) | CA2494704A1 (zh) |
IL (1) | IL166577A0 (zh) |
PL (1) | PL375183A1 (zh) |
WO (1) | WO2004110500A1 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1764352A1 (en) * | 2005-08-17 | 2007-03-21 | Institute of Nuclear Energy Research | A conventional method for the preparation of new precursor of no-carrier-adde O-(2-[18F]fluoroethyl)-L-tyrosine |
JP2007112725A (ja) * | 2005-10-18 | 2007-05-10 | Inst Nuclear Energy Research Rocaec | 無支持体の18Fで標識したアミノ酸O−(2−[18F]fluoroethyl)−L−Tyrosineの製造方法。 |
US20080293969A1 (en) * | 2005-11-22 | 2008-11-27 | Ge Healthcare Limited | 18F-Labeled Daa Analogues and Method of Labeling These Analogues as Positron Emission Tomography (Pet) Tracers For Imaging Peripheral Benzodiazepine Receptors |
EP1923382A1 (de) * | 2006-11-18 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | [F-18] markierte L-Glutaminsäure, [F-18] markiertes Glutamin, ihre Derivate und ihre Verwendung sowie Verfahren zu ihrer Herstellung |
WO2008052788A1 (de) * | 2006-11-01 | 2008-05-08 | Bayer Schering Pharma Aktiengesellschaft | [f-18] markierte l-glutaminsäure, [f-18] markiertes l-glutamin, ihre derivate und ihre verwendung sowie verfahren zu ihrer herstellung |
EP2123621A1 (de) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
EP2271373B1 (en) * | 2008-03-10 | 2018-10-31 | The Medical College Of Wisconsin, Inc. | 99mtc-labeled 19 amino acid containing peptide for use as phosphatidylethanolamine binding molecular probe and radiopharmaceutical |
EP2123619A1 (de) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma AG | Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
EP2123620A1 (en) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
CN101723849B (zh) * | 2008-10-10 | 2012-11-21 | 北京师范大学 | 18f标记氨基酸类衍生物、其制备方法及其制备报告肿瘤的正电子发射断层显像分子探针中的应用 |
WO2010040854A1 (en) | 2008-10-10 | 2010-04-15 | Merck Eprova Ag | 18f-labelled folates as pet radiotracers |
CN101723850B (zh) * | 2008-10-10 | 2012-11-21 | 北京师范大学 | 18f标记芳香氨基酸及其制备方法和肿瘤显像应用 |
JP2012510958A (ja) * | 2008-12-04 | 2012-05-17 | バイエル ファーマ アクチエンゲゼルシャフト | 放射性同位体で標識されたリジン及びオルニチン誘導体、それらの使用及び製造方法 |
US8722014B2 (en) * | 2009-05-01 | 2014-05-13 | Washington University | 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof |
JP5590540B2 (ja) * | 2009-05-13 | 2014-09-17 | 国立大学法人東北大学 | ポジトロン標識タンパク質の合成方法 |
JP2013510891A (ja) * | 2009-11-17 | 2013-03-28 | バイエル・ファルマ・アクチェンゲゼルシャフト | F−18標識のグルタミン酸誘導体の製造法 |
WO2014126071A1 (ja) * | 2013-02-12 | 2014-08-21 | 国立大学法人大阪大学 | 芳香族アミノ酸誘導体およびそれを用いるpetプローブ |
WO2015152128A1 (ja) * | 2014-03-31 | 2015-10-08 | 長瀬産業株式会社 | アミノ酸前駆体、アミノ酸およびその製造方法、ならびに該アミノ酸を用いたpet診断用トレーサー |
JP6448231B2 (ja) * | 2014-06-27 | 2019-01-09 | 浜松ホトニクス株式会社 | 放射性標識化合物 |
WO2018035610A1 (en) * | 2016-08-23 | 2018-03-01 | Simon Fraser University | 18f labeled amino acids, derivatives thereof and method of making same |
JP7368854B2 (ja) * | 2018-03-15 | 2023-10-25 | 国立大学法人大阪大学 | 211At標識化アミノ酸誘導体を含む医薬組成物及びその製造方法 |
CN109091681B (zh) * | 2018-08-09 | 2021-08-03 | 中山大学附属第一医院 | [18f]三氟甲基含硫氨基酸类pet显像剂及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1220591A (en) * | 1914-05-22 | 1917-03-27 | Guggenheim Laundry Machinery Company | Laundry machinery. |
GB1220591A (en) | 1967-05-26 | 1971-01-27 | Rit Rech Ind Therapeut | Beta-phenylalanine derivatives |
BE720365A (zh) * | 1967-09-11 | 1969-02-17 | ||
DE2818644C2 (de) * | 1978-04-27 | 1983-09-29 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin | Mit radioaktivem Jod markierte 3'-Brom-thyrocarbonsäurederivate und Verfahren zu deren Herstellung |
EP0451422A1 (en) * | 1990-04-13 | 1991-10-16 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutically active fluoromethyltyrosine compounds |
JP3537914B2 (ja) * | 1995-05-18 | 2004-06-14 | 株式会社生体機能研究所 | [18f]フルオロ芳香族化合物の製造法 |
US6187284B1 (en) * | 1997-09-03 | 2001-02-13 | Immunomedics, Inc. | Fluorination of proteins and peptides for F-18 positron emission tomography |
DE10223451A1 (de) * | 2002-05-25 | 2003-12-24 | Abx Gmbh | Verfahren zur Herstellung von 18F-fluorierten alpha-Aminosäuren |
-
2003
- 2003-08-01 KR KR1020057001950A patent/KR20050033067A/ko active IP Right Grant
- 2003-08-01 WO PCT/US2003/024436 patent/WO2004110500A1/en active Search and Examination
- 2003-08-01 US US10/523,184 patent/US7189383B2/en not_active Expired - Fee Related
- 2003-08-01 PL PL03375183A patent/PL375183A1/xx not_active Application Discontinuation
- 2003-08-01 JP JP2005500822A patent/JP2006516547A/ja active Pending
- 2003-08-01 EP EP03816986A patent/EP1539250A1/en not_active Withdrawn
- 2003-08-01 CA CA002494704A patent/CA2494704A1/en not_active Abandoned
- 2003-08-01 AU AU2003304200A patent/AU2003304200B2/en not_active Ceased
- 2003-08-01 CN CN03818609A patent/CN100581589C/zh not_active Expired - Fee Related
-
2005
- 2005-01-30 IL IL16657705A patent/IL166577A0/xx unknown
-
2006
- 2006-12-11 US US11/609,231 patent/US20070081941A1/en not_active Abandoned
Non-Patent Citations (7)
Title |
---|
MONOIODO-D-TYROSINE, AN ARTIFICIAL AMINO ACIDRADIOPHARMACEUTICAL FOR SELECTIVEMEASUREMENT OF MEMBRANE AMINO ACIDTRANSPORT IN THE PANCREAS. KAWAI K ET AL.NUCLEAR MEDICINE AND BIOLOGY,Vol.17 No.4. 1990 |
MONOIODO-D-TYROSINE,AN ARTIFICIAL AMINO ACIDRADIOPHARMACEUTICAL FOR SELECTIVEMEASUREMENT OF MEMBRANE AMINO ACIDTRANSPORT IN THE PANCREAS. KAWAI K ET AL.NUCLEAR MEDICINE AND BIOLOGY,Vol.17 No.4. 1990 * |
Synthesis and radiopharmacology of fluoroethy l tyrosine for tumor imaging. APPLIED RADITION AND ISOTOPES INTERNATIONAL JOURNAL OF RADIATION. 1991 |
Synthesis and radiopharmacology of fluoroethy l tyrosine for tumor imaging. WESTER H J ET AL.JOURNAL OF NUCLEAR MEDICINE,Vol.40 No.1. 1999 |
Synthesis and radiopharmacology of fluoroethy l tyrosine for tumor imaging. APPLIED RADITION AND ISOTOPES INTERNATIONAL JOURNAL OF RADIATION. 1991 * |
UPTAKE AND DISTRIBUTION OF L-3-I-125LODO-ALPHA-METHYL TYROSINE IN EXPERIMENTALRAT TUMOURS:COMPARISON WITH BLOOD FLOW ANDGROWTH RAT. DEEHAN B ET AL.EUROPEAN JOURNAL OF NUCLEAR MEDICIN,Vol.20 No.2. 1993 |
用放射性同位素诊断癌症. 邓吉宜.日本医学介绍,第4期. 1984 |
Also Published As
Publication number | Publication date |
---|---|
JP2006516547A (ja) | 2006-07-06 |
IL166577A0 (en) | 2006-01-15 |
US20060127306A1 (en) | 2006-06-15 |
EP1539250A1 (en) | 2005-06-15 |
US20070081941A1 (en) | 2007-04-12 |
PL375183A1 (en) | 2005-11-28 |
AU2003304200A1 (en) | 2005-01-04 |
CA2494704A1 (en) | 2004-12-23 |
AU2003304200B2 (en) | 2009-10-01 |
WO2004110500A1 (en) | 2004-12-23 |
US7189383B2 (en) | 2007-03-13 |
CN1674943A (zh) | 2005-09-28 |
KR20050033067A (ko) | 2005-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100581589C (zh) | 放射标记的氨基酸类似物,其制备物及用途 | |
Wängler et al. | One-step 18F-labeling of peptides for positron emission tomography imaging using the SiFA methodology | |
Babich et al. | Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides | |
Haubner et al. | [18F] Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates | |
Okarvi | Recent progress in fluorine-18 labelled peptide radiopharmaceuticals | |
Vaidyanathan et al. | Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate | |
Ogawa et al. | Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers | |
Liu et al. | Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging | |
Wang et al. | Evaluation of F-18-labeled amino acid derivatives and [18F] FDG as PET probes in a brain tumor-bearing animal model | |
CN109438517B (zh) | 一种与羰基金属核心配位的双功能连接剂的配合物及其制备方法 | |
CZ20032597A3 (cs) | Analogy kyseliny askorbové pro metaloradiofarmaceutika | |
Ogawa | Development of diagnostic and therapeutic probes with controlled pharmacokinetics for use in radiotheranostics | |
US20220306663A1 (en) | Metal Tricarbonyl Complexes Comprising Substituted Iminodiactic Acid Ligands and Uses as Radioisotope Tracers | |
US5986074A (en) | Metal chelates as pharmaceutical imaging agents, processes of making such and uses thereof | |
CA2165228A1 (en) | Metal chelate forming peptides and use thereof | |
Ishiwata et al. | Evaluation of O-[11C] methyl-L-tyrosine and O-[18F] fluoromethyl-L-tyrosine as tumor imaging tracers by PET | |
Huang et al. | Synthesis and preliminary biological evaluation of S-11 C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging | |
Liu et al. | Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide | |
JPH09512555A (ja) | テクネチウム−99m標識イメージング剤 | |
Chang et al. | Preparation and characterization of a novel Al18F–NOTA–BZA conjugate for melanin-targeted imaging of malignant melanoma | |
Kawai et al. | Monoiodo-D-tyrosine, an artificial amino acid radiopharmaceutical for selective measurement of membrane amino acid transport in the pancreas | |
US4925651A (en) | Radiofluoro-tyrosine derivatives, the preparation and use thereof | |
Schirrmacher et al. | Silicon-based 18F-radiopharmaceuticals: from basic SiFA chemistry toward its clinical application | |
Fedorova et al. | 18 F-labeled tyrosine derivatives: Synthesis and experimental studies on accumulation in tumors and abscesses | |
Suzuki et al. | Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: VRIJE UNIV BRUSSEL Free format text: FORMER OWNER: MALLINCKRODT INC. Effective date: 20100721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: MISSOURI STATE, THE USA TO: BRUSSELS, BELGIUM |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100721 Address after: Brussels Patentee after: VRIJE Universiteit Brussel Address before: American Missouri Patentee before: Mallinckrodt Inc. |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100120 Termination date: 20110801 |